A Kahneman lens clinicians can feel in their bones
Daniel Kahneman (Nobel Prize in Economic Sciences) popularized 2 different types of thinking in Thinking, Fast and Slow: System 1 is fast pattern recognition; System 2 is slower, deliberate analysis.
If you’ve ever run a massive transfusion in a crashing patient, you already know the two systems. System 1 is the trauma bay’s “autopilot”: pattern recognition, rehearsed roles, and rapid action under uncertainty. System 2 is the calm, later conversation: What exactly happened? Did we help or just feel busy? How do we make the next case safer? Kahneman popularized this dual-process view (System 1 fast/automatic; System 2 slow/effortful).
REBOA is a perfect System 1 trigger because it is highly salient: you can see numbers change quickly, and the story is memorable. That’s a feature in the moment; and a bias when deciding policy, purchasing, credentialing, and who “counts” as an ideal candidate.
Biases that quietly shape pro- and anti-REBOA arguments
The availability heuristic (we judge likelihood and value by what comes easily to mind) explains why a single dramatic save or a single catastrophic death can dominate a team’s collective opinion. A “pro” System 1 narrative is “pressure snapped back; the patient lived.” An “anti” narrative is “we lost time and the patient died.” Both are emotionally honest, and both can mislead policy.
Confirmation bias then hardens positions: once someone is “pro” or “anti,” they unconsciously interpret new data in a way that supports the prior belief. You see this when the same RCT is framed as “proof REBOA is harmful” vs “proof REBOA was used in the wrong system.”
Loss aversion makes leaders (and clinicians) overweight the regret of causing a complication via action compared with the regret of not having a tool available. That often fuels status‑quo decisions-especially when adverse events are visible and blameable.
Status quo bias adds inertia: organizations disproportionately stick with current practice even when a change might help a subset, unless the change is made safer through governance and measurement.
REBOA Center of Gravity
A balanced, evidence-based approach to REBOA sounds like this: REBOA can be beneficial when it is used for the right physiology (likely below-diaphragm hemorrhage), in
the right hands (rapid CFA access, practiced workflow), with the right clock (tight balloon-time limits and no delay to hemostasis). The strongest programmatic argument is not that REBOA always improves outcomes. It’s that a disciplined REBOA program can reduce preventable deaths in carefully selected patients while controlling predictable risks.
System 2 recommendations for clinicians and hospital leaders
Clinicians can protect patients by deciding in advance what “good REBOA” looks like: a short checklist (confirm suspected subdiaphragmatic source; avoid contraindications like major thoracic hemorrhage/tamponade; define zone and target occlusion strategy; document inflation time; confirm immediate hemostasis pathway). This aligns with the ACS/ACEP focus on indications and the JTS focus on time limits and monitoring.
Hospital leaders can prevent REBOA from becoming a “hero procedure” by treating it as a program: credentialing and simulation, minimum staffing expectations, explicit time-to-definitive-control targets, and disciplined QI/registry participation. The goal is to ensure REBOA functions as a bridge and not a detour.
More Lessons from Kahneman: When the Clock Is Bleeding
Kahneman reminds us that humans are poor intuitive statisticians. Under pressure, we rely on stories rather than base rates. In trauma, this is almost unavoidable. The resuscitation room rewards decisive action, not philosophical reflection. But the same mental shortcuts that allow a team to act quickly can also distort how we judge tools like REBOA. A single dramatic save can make a technology feel indispensable; a single complication can make it feel reckless. The reality, as Kahneman would predict, is more nuanced.
Another idea from Thinking, Fast and Slow is the planning fallacy; our tendency to underestimate how long complex tasks actually take. In trauma care, minutes matter, and every intervention competes with the same scarce resource: time to definitive hemorrhage control. REBOA works best when teams realistically understand their workflow. When access is rapid, roles are practiced, and the path to the OR or angio suite is immediate, REBOA can buy precious time for patients with catastrophic bleeding below the diaphragm. When those systems are not in place, the same intervention can unintentionally become a delay rather than a bridge.
Kahneman also described overconfidence in expert judgment. Trauma surgeons are highly trained pattern recognizers, and rightly so; experience saves lives. Yet even the best clinicians benefit from structured decision-making. Protocols, checklists, and programmatic governance are not signs of uncertainty; they are tools that help convert System 1 expertise into safer System 2 decisions. When applied in that disciplined way, REBOA becomes what it was always meant to be: not a hero maneuver, but a controlled, temporary strategy to stabilize the right patient while definitive hemorrhage control is achieved.
